Key facts
- Medical Brain (New York)’s last known valuation is $115.0M (Feb 2025).
- It has raised $55.8M; the latest was Later Stage VC ($20.0M) in Aug 2025.
- Notable investors include Seed Healthcare, Thornapple River Capital.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Medical Brain (New York)
- ·The full record, as it builds
Funding rounds
No funding rounds for Medical Brain (New York) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Medical Brain (New York)
Developer of a clinical decision support platform designed to monitor and address patient health in real-time. The company's platform utilizes artificial intelligence to analyze patient data and provide evidence-based recommendations and best practices, predict future health risks, and send timely notifications, enabling healthcare providers to improve clinical decision-making, streamline workflows, and enhance care coordination.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2017
- Employees
- 63
- Website
- medicalbrain.com/
- Ownership
- Privately Held (backing)
Medical Brain (New York) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Medical Brain (New York) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Medical Brain (New York) in its N-PORT filings yet. We sweep new filings monthly.